CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2018; 54(03): 120-146
DOI: 10.1055/s-0040-1712839
Review Article

Current Concepts of Pathophysiology of Vasovagal Syncope and its Evaluation and Management: A Review

Mohan B Dikshit
Formerly in the Department of Physiology, Institute of Aerospace Medicine IAF, Bunguluru
Formerly in the Department of Physiology, Department of Clinical Physiology, SQUH Hospital, Sultan Qaboos University, Muscat, Oman
,
Deepali S Jaju
Formerly in the Department of Physiology, Department of Clinical Physiology, SQUH Hospital, Sultan Qaboos University, Muscat, Oman
› Author Affiliations

ABSTRACT

Vasovagal syncope (VVS) with a sudden, temporary loss of consciousness (LoC) is a common phenomenon in the young and the elderly. Though generally described as innocuous, it may lead to serious consequences in special category of people (pilots), or in the elderly in whom LoC may lead to a fall and serious injury. The topic has been copiously researched upon and discussed in medical literature over the last few decades, but the exact mechanisms which lead to the disability have yet to be fully agreed upon. Changes in cardiovascular baroreceptor sensitivity, aberrations in the complex interaction amongst the nucleus of the tractus solitarius and the nuclei around it, inability of the peripheral circulation to respond to autonomic vasoconstrictors, or excess production of vasodilators such as nitric oxide produced locally have been considered in its pathophysiology. Various extraneous situations like dehydration, exposure to heat stress, medications, psychological factors may adversely stress regulatory physiological responses and promote occasional episodes of VVS. More complex dysautonomia could be a reason for the recurrent VVS. Differences between brain structure of VVS sufferers and normal subjects have been proposed. Head-up tilt table (HUT) test is the most widely applied investigation for evaluating VVS episodes. Lower body negative pressure (LBNP) has also been used. Enhancement of the orthostatic stress may be done by simultaneous use of both, or with peripheral vasodilators. As to whether such an enhancement is necessary is debatable. Management with increased salt and fluid intake, corticosteroids, beta adrenergic receptor blockers, alpha adrenergic receptor stimulants, selective serotonin reuptake inhibitors, and nitric oxide synthase inhibitors have been tried with variable success.



Publication History

Article published online:
09 May 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Dikshit MB (1996). Syncope. An enigma in aviation physiology. In: Peripheral Elements of the Nervous System. M Fahim, ed. Vallabhbhai Patel Chest Institute, Delhi: Computronix, 59-72.
  • 2 Wayne HH (19 61) . Sy ncope. Physiological considerations and an analysis of the clinical characteristics in 510 patients. Am J Med 30: 418-438.
  • 3 Kapoor WN, Karpf M, Maher Y, Miller RA, Levey GS (1982). Syncope of unknown origin. The need for a more cost-effective approach to its diagnosis evaluation. J Am Med Assoc 247: 2687-2691.
  • 4 Kapoor WN (2000). Review article: primary care. Syncope N Engl J Med 343:1856-1862.
  • 5 Lambert E, Lambert GW (2014). Sympathetic dysfunction in vasovagal syncope and the postural orthostatic tachycardia syndrome. Front Physiol 5: 290.
  • 6 Malamud-Kessler C, Bruno E, Chiquete E, Sentes- Madrid H, Campos- Sanchez M (2016). Pathophysiology of neurally mediated syncope. Neurolgia 31: 620-627.
  • 7 Vogt FB (1967). Tilt table and plasma volume changes with short term deconditioning experiments. Aerosp Med 38: 564-568.
  • 8 Hickler RB, Hoskin RG, Hamlin JT (1960). The clinical evaluation of faulty orthostatic mechanisms. Med Clin North Am 44: 1237-1250.
  • 9 da Silva RM (2014). Syncope: epidemiology, etiology, and prognosis. Front Physiol 5: 471.
  • 10 Lavania AK, Talwar R, Dikshit MB (1988). Incidence of syncope amongst healthy young people. Indian J Physiol Pharmacol 34(suppl 1): 319-320.
  • 11 Dikshit MB, Banerjee PK, Rao PLN (1986). Orthostatic tolerance of normal Indians and of those with suspected abnormal cardiovascular reflex status. Aviat Space Environ Med 57: 168-173.
  • 12 Seifer CM, Kenny RA (2001). Head-up tilt testing in children. Eur Heart J 22: 1968-1971.
  • 13 van Dijk JG (2003). Fainting in animals. Clin Auton Res 13: 247–255.
  • 14 Alboni P, Alboni M (2014). Vasovagal syncope as a manifestation of an evolutionary selected trait. J Atr Fibrillation 7: 97-102.
  • 15 Dikshit MB (1987). Postural stress tests for the clinicophysiological evaluation of cardiovascular reflexes. Indian J Physiol Pharmacol 31: 1-12.
  • 16 Dikshit MB, Chatterjee PC (1976). Changes in orthostatic tolerance during short duration mild hypoxia. Aviat Med 20: 9-14.
  • 17 Dikshit MB, Banerjee PK, Rao PLN, Iyer EM (1986). Left ventricular ejection time based cardiac output changes in pilots and non-pilots during orthostatic stress. Indian J Med Res 83: 301-303.
  • 18 Dikshit MB, Banerjee PK, Rao PLN, Iyer EM (1986). Systolic time intervals in pilots and non-pilots during 700 head-up tilt. Aviat Space Environ Med 57: 332-335.
  • 19 Dikshit MB, Fentem PH, Macdonald IA, Patrick JM (1987). Immediate and delayed effects of temazepam on human orthostatic reflexes. Br J Clin Pharmacol 24: 254-255.
  • 20 Dikshit MB (1990). Lower body suction and cardiovascular reflexes: physiological and applied considerations. Indian J Physiol Pharmacol 34: 3-12.
  • 21 Dikshit MB, Lavania AK, Devdikar RS, Prasad BAK, Jog NV, Ganguli SS (1991). Calcium channel blockers and the CVS reflex responses during LBSP. Indian J Physiol Pharmacol 35: 232-236.
  • 22 Dikshit MB (1983). Comparative cardiovascular response to 70 degrees head up tilt in pilots and nonpilots. Aviat Med 27: 36-42.
  • 23 Dikshit MB, Banerjee PK, Kulkarni JS, Iyer EM, Singh MM (1984). Medical evaluation of cosmonauts: physiological stress testing. Aviat Med 28: 107-115.
  • 24 Patel K, Rössler A, Lackner HK, et al (2016). Effect of postural changes on cardiovascular parameters across gender. Medicine (Baltimore) 95: e41-e49.
  • 25 Sachse C (2017). Gender Differences in Cardiovascular Responses to Orthostatic Challenge in Healthy Older Persons. MD Thesis. Med University Graz.
  • 26 Park J, Jang SY, Yim HR, et al ( 2010). Gender difference in patients with recurrent neurally mediated syncope. Yonsei Med J 51: 499–503.
  • 27 Goldstein IB, Shapiro D (1995). The cardiovascular response to postural change as a function of race. Biol Psycho 39: 173-186.
  • 28 Patrick JM, Dikshit MB, Macdonald IA, Fentem PH (1987). Human orthostatic reflexes after taking temazepam at night. Br J Clin Pharmacol 24: 799-807.
  • 29 Sjostrand T (1952). The regulation of blood distribution in man. Acta Physiol Scand 26: 312-327.
  • 30 Ewing DJ, Hume L, Campbell IW, Murray A, Neilson JM, Clarke BF (1980). Autonomic mechanisms in the initial heart rate response to standing. J Appl Physiol Respir Environ Exerc Physiol 49: 809-814.
  • 31 Jaju DS, Dikshit MB, Purandare VR, Raje S (2004). Heart rate and blood pressure responses of left handers and right handers to autonomic stressors. Indian J Physiol Pharmacol 48: 31-40.
  • 32 Jaju DS (2008). Blood Pressure and Cardiovascular Control in Offspring of Hypertensive and Normotensive Parents from Large Homogeneous Omani Arab Pedigrees. PhD Thesis. Graz Teaching Hospital and Institute of Physiology Medical University Graz.
  • 33 Rea RF, Wallin G (1989). Sympathetic nerve activity during lower body negative pressure in humans. J Appl Physiol 66: 2778-2781.
  • 34 Grassi G, Gavazzi C, Cesura AM, Picotti GB, Mancia G (1985). Changes in plasma catecholamines in response to reflex modu lation of sympa t hetic vasoconstrictor ton by cardio-pulmonary receptors. Clin Sci 68: 503-510.
  • 35 Paintal AS (1963). Natural stimulation of type B receptors. J Physiol (London) 169: 116-136.
  • 36 Gauer OH, Henry JP (1963). Circulatory basis of fluid volume control. Physiol Rev 48: 423-481.
  • 37 Hainsworth R (2014). Cardiovascular control from cardiac and pulmonary vascular receptors. Exp Physiol 99: 312–319.
  • 38 Grimm DR (1997). Neurally mediated syncope: a review of cardiac and arterial receptors. J Clin Neurophysiol 14: 170-182.
  • 39 Abboud FM, Heisted DD, Mark AL, Schmid PG (1976). Reflex control of peripheral circulation. Prog Cardiovasc Dis 18: 371-403.
  • 40 Anonymous (2012). Cardiovascular regulatory mechanisms, Chapter 32. In: Ganong's Review of Medical Physiology. Barrett KE, Barman SM, Boitano S, Brooks HL, eds. New York: McGraw Hill Medical, 587-600.
  • 41 Tripathi A, Nadel ER (1986). Forearm and muscle vasoconstriction during lower-body negative pressure. J Appl Physiol 60: 1535-1541.
  • 42 Chen CY, Ling Eh EH, Horowitz JM, Bonham AC (2002). S ynaptic transmission in nucleus tractus solitarius is depressed by Group II and III but not Group I presynaptic metabotropic glutamate receptors in rats. J Physiol 538: 773–786.
  • 43 Sapru HN (2004). Neurotransmitters in the nucleus tractus solitarius mediating cardiovascular function. In: Neural Mechanisms of Cardiovascular Regulation. Dun NJ, Machado BH, Pilowsky PM, eds. Boston, MA: Springer, 81-98.
  • 44 Thoren P (1979). Role of cardiac vagal C-fibers in cardiovascular control. Rev Physiol Biochem Pharmacol 86: 1–94.
  • 45 Chen CY, Bonham AC (2005). Glutamate suppresses GABA release via presynaptic metabotropic glutamate receptors at baroreceptor neurones in rats. J Physiol 562 (Pt 2): 535–555.
  • 46 Sekizawa S, Bechtold AG, Tham RC, Bonham AC (2009). A novel postsynaptic Group II metabotropic glutamate receptor role in modulating baroreceptor signal transmission. J Neuroscience 29: 11807-11816.
  • 47 Longhurst J (2008). Neural regulation of the cardiovascular system, Chapter 36. In: Fundamentals of Neuroscience, 3rd edn. Squire LR, Berg D, Bloom F, du Lac S, Ghosh A, Spitzer N, eds. Tokyo: Elsevier, 829-853.
  • 48 Hassen AH, Feuerstein G (1987). mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. Am J Physiol 252: H156-H162.
  • 49 Schobel HP, Orem RM, Mark AL, Ferguson DW (1992). Naloxone potentiates cardiopulmonary baroreflex sympathetic control in normal humans. Cir Res 70: 172-183.
  • 50 Wallbridge DR, Maclntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM (1996). Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J 17: 1729-1736.
  • 51 Jordan D (2004). Vagal control of the heart: central serotonergic (5-HT) mechanisms. Exp Physiol 90: 175–181.
  • 52 Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A (1999). Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33: 1227–1230.
  • 53 Epstein FH (1993). The L Arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012.
  • 54 Allen JD, Giordano T, Kevil CG (2012). Nitrite and nitric oxide metabolism in peripheral artery disease. Nitric Oxide 15: 217-222.
  • 55 Bonanno FG (2011). Physiopathology of shock. J Emerg Trauma Shock 4: 222–232.
  • 56 Davenport AP, Hyndman KA, Dhaun N, et al (2016). Endothelin. Pharmacol Rev 68: 357–418.
  • 57 Grubb BP (2005). Neurocardiogenic syncope. N Engl J Med 352: 1004-1010.
  • 58 Graham LA, Kenny RA (2001). Clinical characteristics of patients with vasovagal reactions presenting as unexplained syncope. Europace 3: 141–146.
  • 59 Grubb BP, Gerard G, Roush K, et al (1991). Differentiation of convulsive syncope and epilepsy with head-up tilt. Ann Intern Med 115: 871-876.
  • 60 Lin JT, Ziegler DK, Lai WV, Bayer W (1982). Convulsive syncope in blood donors. Ann Neurol 11: 525-528.
  • 61 Jaju DS (2018). Un published observations: post syncopal symptoms.
  • 62 Raj SR (2006). The postural tachycardia syndrome (POTS): pathophysiology, diagnosis and management. Indian Pacing Electrophyiol J 6: 84-99.
  • 63 Garland EM, Celedonio GE, Raj SR (2015). Postural tachycardia syndrome: beyond orthostatic intolerance. Curr Neurol Neurosci Rep 15: 60.
  • 64 Kenny RA, McNicholas T (2016). The management of vasovagal syncope. Qtly J Med 109: 767–777.
  • 65 Raj SR, Coffin ST (2013). Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension. Prog Cardiovasc Dis 55: 425–433.
  • 66 Vaddadi G, Guo L, Esler M, et al (2011). Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol 4: 711-718.
  • 67 Wallin BG , Sundlöf G (1982). Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 6: 287-291.
  • 68 Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, et al (1997). Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 99: 2736–2744.
  • 69 Bechir M, Binggeli C, Corti R, et al (2003). Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation 107: 1620–1625.
  • 70 Furlan R, Perego F, Colombo S (2004). Baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation 109: e171.
  • 71 Beacher FD, Gray MA, Mathias CJ, Critchley HD (2009). Vulnerability to simple faints is predicted by regional differences in brain anatomy. Neuroimage 47: 937–945.
  • 72 Kim JB, Suh SI, Seo WK, Koh SB, Kim JH (2014). Right insular atrophy in neurocardiogenic syncope: a volumetric MRI study. Am J Neuroradiol 35: 113–118.
  • 73 Park BS, Lee J Y, Park J, et al (2018). Alterations of brain network hubs in reflex syncope: evidence from a graph theoretical analysis based on DTI. Brain Behav 8: e01006.
  • 74 Stewart JM, Sutton R, Kothari ML, et al (2017). Nitric oxide synthase inhibition restores orthostatic tolerance in young vasovagal syncope patients. Heart 103: 1711–1718.
  • 75 Toda N, Okamura T (2003). The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 55: 271–324.
  • 76 Zanzinger J (1999). Role of nitric oxide in the neural control of cardiovascular function. Cardiovas Res 43: 639–664.
  • 77 Yamanouchi Y, Jaalouk S, Shehadeh AA, Jaeger F, Goren H, Fouad-Tarazi FM (1996). Changes in left ventricular volume during head-up tilt in patients with vasovagal syncope: an echocardiographic study. Am Heart 131: 73–80.
  • 78 Novak V, Honos G, Schondorf R (1996). Is the heart “empty” at syncope? J Auton Nerv Syst 60: 83–92.
  • 79 Davrath LR, Gotshall RW, Tucker A, et al (1999). The heart is not necessarily empty at syncope. Avia Space Environ Med 70: 213-219.
  • 80 Fitzpatrick AP, Banner N, Cheng A, Yacoub M, Sutton R (1993). Vasovagal reactions may occur after orthotopic heart transplantation. J Am Coll Cardiol 21: 1132-1137.
  • 81 Santini M, Ammirati F, Colivicchi F, Gentilucci G, Guido V (1999). The effect of atropine in vasovagal syncope induced by head-up tilt testing. Eur Heart J 20: 1745-1751.
  • 82 Swenne CA (2013). Baroreflex sensitivity: mechanisms and measurement. Neth Heart J 21: 58-60.
  • 83 O'Leary DD, Kimmerly DS, Cechetto AD, Shoemaker JK (2003). Differential effect of head-up tilt on cardiovagal and sympathetic baroreflex sensitivity in humans. Exp Physiol 88: 769–774.
  • 84 Mitro P, Simurda M, Muller E (2018). Improvement in low upright baroreflex sensitivity is associated with positive clinical effect of orthostatic training. Pacing Clin Electrophysiol 41: 42-49.
  • 85 Cheng CA, Lee JT, Chiu HW (2010). Modifications of autonomic activity and baroreceptor response during tilt-induced vasovagal syncope. Computing in Cardiol 37: 943-946.
  • 86 Rosengard-Barlund M, Bernardi L, Sandelin A, Forsblom C, Groop PH; FinnDiane Study Group (2011). Baroreflex sensitivity and its response to deep breathing predict increase in blood pressure in type 1 diabetes in a 5-year follow-up. Diabetes Care 34: 2424-2430.
  • 87 La Rovere MT, Pinna GD, Maestri R, Sleight P (2013). Clinical value of baroreflex sensitivity. Neth Heart J 21: 61–63.
  • 88 Leonelli F, Wang Ke, Evans J, et al (2000). False positive head-up tilt: hemodynamic and neurohumoral profile. J Amer Coll Cardiol 35: 188 –193.
  • 89 Jacob G, Ertel AC, Shannon JR, Furlan R, Robertson RM, Robertson D (1998). Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol 84: 914–921.
  • 90 Zarvalis E, Theodorakis GN, Flevari P, Livanis EG, Markianos E, Kremastinos D Th (2004). Hormonal responses during neurally mediated syncope as an indication of central serotonergic activity. Hellenic J Cardiol 45: 8-13.
  • 91 Jardine DL, Melton IC, Crozier IG, Bennett SI, Donald RA, Ikram H (1997). Neurohormonal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 79: 1302-1306.
  • 92 Ertl AC, Diedrich A, Biaggion I (2000). Baroreflex dysfunction induced by microgravity: potential relevance to postflight orthostatic intolerance. Clin Auton Res 10: 269-277.
  • 93 Di Rienzo M, Castiglioni P, Iellamo F, et al (2008). Dynamic adaptation of cardiac baroreflex sensitivity to prolonged exposure to microgravity: data from a 16-day spaceflight. J Appl Physiol 105: 1569–1575.
  • 94 Eckberg DL, Halliwill JR, Beightol LA, Taylor A, Goble R (2010). Human vagal baroreflex mechanisms in space. J Physiol 588 (Pt 7): 1129–1138.
  • 95 Madden K, Lockhart C (2013). Arterial baroreflex function in older adults with neurocardiogenic syncope. Clin Invest Med 32: E191-E198.
  • 96 Goyal P, Maurer MS (2016). Syncope in older adults. J Geriatr Cardiol 13: 380-386.
  • 97 Kenny RA, McNicholas T (2016). The management of vasovagal syncope. Qtly J Med 109: 767-773.
  • 98 O'Brien H, Kenny RA (2014). Syncope in the elderly. Eur Cardiol Rev 9: 28-36.
  • 99 Sagrista-Sauleda J, Romero-Ferrer B, Moya A, Permanyer-Miralda G, Soler-Soler J (2001). Variations in diagnostic yield of h ea d-up ti l t t est and electrophysiology in groups of patients with syncope of unknown origin. Eur Heart J 22: 857–865.
  • 100 Brignole M, Moya A, de Lange FJ, et al (2018). ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 39: 1883–1948.
  • 101 Sutton R, Bloomfield DM (1999). Indications, methodology, and classification of results of tilt-table testing. Am J Cardiol 84: 10Q-19Q.
  • 102 Forleo C, Guida P, Iacoviello M, et al (2013). Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Intl J Cardiol 168: 27–35.
  • 103 Dehghan B, Sabri MR (2016). Comparison of short head-up tilt test with conventional protocol after omission of nonmedicated phase in children and young adults. Adv Biomed Res 5: 207-213.
  • 104 Dikshit MB (1992). Cardiovascular reflex adjustments for aerospace application, Chapter 38. In: Advances in Physiological Sciences. Manchanda S, Selvamurthy W, Mohan Kumar V, eds. Delhi: Macmillan, 263-271.
  • 105 Kitano A, Shoemaker JK, Ichinose M, Wada H, Nishiyasu T (2005). Comparison of cardiovascular responses between lower body negative pressure and head-up tilt. J Appl Physiol 98: 2081-2086.
  • 106 El-Bedawi KM, Hainsworth R (1994). Combined head-up tilt and lower body suction: a test of orthostatic tolerance. Clin Auton Res 41: 41-47.
  • 107 Vaddadi G, Lambert E, Corcoran SJ, Esler MD (2007). Postural syncope: mechanisms and management. Med J Aust 187: 299-304.
  • 108 Verheyden B, Ector H, Aubert AE, Reybrouck T (2008). Tilt training increases the vasoconstrictor reserve in patients with neurally mediated syncope evoked by head-up tilt testing. Eur Heart J 29: 1523-1530.
  • 109 Tyagi A, Cohen M (2016). Yoga and heart rate variability: a comprehensive review of literature. Intl J Yoga 9: 97-113.
  • 110 Gunda S, Kanmanthareddy A, Atkins D, et al (2015). Role of yoga as an adjunctive therapy in patients with neurocardiogenic syncope: a pilot study. J Interv Card Electrophysiol 43: 105-110.
  • 111 Wadhawan JM, Dikshit MB, Chatterjee PC (1985). Some aspects of yogic exercises during space flight. Aviat Med 29: 31-37.